NCT03604198 2026-02-19Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing SyndromeCorcept TherapeuticsPhase 2 Active not recruiting125 enrolled
NCT02721732 2026-01-29Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are MetastaticM.D. Anderson Cancer CenterPhase 2 Active not recruiting157 enrolled 26 charts